Le Lézard
Classified in: Health, Business
Subjects: PDT, CXP

Canndescent® Launches "goodbrandstm", A Brand To Help Premium Consumers Navigate Cannabis



SANTA BARBARA, Calif., Oct. 11, 2018 /PRNewswire/ -- Luxury cannabis house Canndescent has launched a new, sun grown brand?goodbrandstm--targeting premium consumers who desire natural, easy-to-understand cannabis products.  goodbrands, which offers products under the names goodflowertm, goodjointstm, goodeatstm, and goodoilstm, harnesses state-of-the-art greenhouses and the California sun to produce high value cannabis products at a more accessible price point.  goodbrands, Canndescent's encore offering, reflects the company's strategy of expanding vertically and horizontally on shelf launching more brands and product lines.

goodflower

True to its parent company's mission of helping consumers unlock the moment with cannabis, goodbrands is the first offering to simplify cannabis for the premium market with an effects-based architecture.  The initial offering from goodbrands, goodflower, is a full spectrum, light dep flower that comes in five distinct categories:

Soft launched to stores on August 7, 2018, goodflower surged in its inaugural month and completed it by outselling Canndescent, California #1-selling flower brand in 2017.  Addressing goodflower's immediate success, CEO, Adrian Sedlin, said, "The brand solves against a glaring unmet need in the vast middle market by combining simplicity, affordability, quality, and purity; we expected this." Responding to questions about potential cannibalization, Canndescent CMO, Jenna Habayeb volunteered, "Our data supports the opposite conclusion and speaks to a growth opportunity."  She continued, "Canndescent is our ultra-premium, indoor, cannabis experience, delivering unmatched luxury to the top shelf consumer; goodflower compliments it, with affordable and shoppable sun grown products that democratize access to quality."

The brand's website, www.goodflwer.com, and packaging reads, "goodflower is the official cannabis of good times and natural living.  We grow the best varieties under the California sun, using sustainable practices, fair wages, pure waters, and no pesticides."  It uses the tagline, "good practices. good health. good times," and currently sells for roughly 65% of the MSRP of the flagship brand.  The company will follow up the goodflower launch later this year with goodjoints and will further extend the new brand house with goodoils in the first half of 2019.

For More information contact
Rosie Mattio
(917) 583-6349

About Canndescent
Canndescent (pronounced Can-Des-Ent) is a luxury, house of brands that helps adults turns down the noise, unlock the moment, and transform their lives with cannabis.  In 2016, Canndescent became the first cultivator in the world to abandon traditional strain names, implementing a more shoppable, strain architecture of Calm, Cruise, Create, Connect and Charge. The company produces over 10,000 pounds of cannabis each year and is often described as the inventor of luxury cannabis. Consumers can purchase Canndescent and its new offering, goodbrands, at leading dispensary and delivery services throughout California and can learn more about the company at www.canndescent.com or www.goodflwr.com

 

goodflower

SOURCE Canndescent


These press releases may also interest you

at 06:30
As per the TMR report, the global Non-vascular Stents Market is predicted to be worth US$730.5 mn between 2017 and 2025. The CAGR is estimated to be 5.0% by the end of 2025. Based on categorization by Product, the global market is seen to draw more...

at 06:30
Prometic Life Sciences Inc.  ("Prometic" or the "Corporation") announced today that it has completed a Type C meeting in which the FDA agreed with the Company's proposed action plan for the...

at 06:18
GB Sciences, Inc. announces the harvesting of its first hemp crop in association with the Colorado Hemp Project. Following closely on the overall philosophy and strategy of the Company, hemp is planned to provide both a reliable source of hard to...

at 06:18
Alphamab Oncology announced that it has received US FDA's IND approval for its proprietary HER2 bispecific antibody (product code: KN026), and KN026 is anticipated to enter clinical development later in the US. With the earlier IND approval for KN026...

at 06:17
Cellenkos, Inc., a clinical-stage biotechnology company, announced that the United States Food and Drug Administration has cleared its Investigational New Drug (IND) application to proceed with a phase I clinical trial of CK0801, allogeneic cord...

at 06:15
The global glycomics/glycobiology market size is expected to reach USD 2.1 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 14.4% over the forecast period. Rising focus on glycomics and...




News published on 11 october 2018 at 10:42 and distributed by: